0.12Open0.12Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover84.60%IV21.04%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier27DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type-0.1469Delta0.1615Gamma51.50Leverage Ratio-0.0059Theta-0.0007Rho-7.56Eff Leverage0.0039Vega
LifeStance Health Stock Discussion
TQ2 '24: Net loss: $23.3m Revenue: $312.3m, up 20% YoY Clinician base: Up 14% to 6,984 Visit volumes: Up 15% to 2m Adj. EBITDA: $28.6m, up 103% YoY '24 guidance: Rev. $1.2b-$1.242b, Center Margin $363m-$383m, Adj. EBITDA $90m-$100m.
No comment yet